Featured Articles

  1. Contrast In Oligonucleotides 3/13/2024

    Explore the differences between research-use-only oligonucleotides and those manufactured in compliance with GMP 21 CFR 820.

  2. Vaccine Maker's Toolkit: Strategies For Manufacturing And Supply Management 11/7/2023

    This collection of insights highlights strategies and guidance to ensure reliable biomanufacturing capacity and supply chains for the delivery of health technologies, even during crisis conditions.

  3. Streamlining Biomanufacturing Automation With Connectivity And Integration 10/29/2023

    Gain insight into the recent advancements in connectivity and integration technology, the associated challenges, and the importance of a vendor-neutral approach.

  4. Economics For Vaccine Manufacturing: Comparing Traditional To Modern Modalities 9/11/2023

    Explore key points from the presentation MilliporeSigma delivered on the analysis and comparison of manufacturing costs between traditional and modern vaccines at the World Vaccine Congress Washington 2023.

  5. Determining RNA Integrity And Purity By Capillary Gel Electrophoresis 6/30/2023

    To ensure mRNA product quality, it's important to confirm the integrity of the RNA. Examine the results of a study challenging the performance of the CGE method in assessing mRNA integrity and purity.

  6. Lipid Nanoparticle Compositional Analysis By UHPLC-CAD 6/30/2023

    Explore results generated from an internal study using a proprietary mRNA-LNP formulation and UHPLC-CAD, a powerful technique for the analysis of compounds that do not contain chromophores.

  7. Establishing Analytical Methods For mRNA-Based Therapies 6/13/2023

    Here, we provide a detailed description of assays for sequence identification and LNP composition in mRNA-LNP products that support the development of safe and effective mRNA therapies.

  8. Modeling The Economics Of Vaccine Manufacturing 5/26/2023

    Here, we describe the use of a custom-designed cost model to explore the economics of vaccine manufacturing when using different modalities.

  9. How Data Analytics Accelerates Transition To Bioprocessing 4.0 4/7/2023

    Following successful Industry 4.0 implementation in the automotive, communications, aerospace, and other industries, the biopharma industry is now joining the digital revolution.

  10. mRNA Process And Cost Modeling: A Tool To Optimize Process Development 3/10/2023

    Demand for mRNA-based medicine production continues to increase, as do investments in prophylactic and therapeutic indications. Explore a cost-model that compares all modalities.